logo
Haitians with HIV defy stigma as they publicly denounce USAID cuts and dwindling medication

Haitians with HIV defy stigma as they publicly denounce USAID cuts and dwindling medication

PORT-AU-PRINCE, Haiti (AP) — A video showing dozens of people marching toward the office of Haiti's prime minister elicited gasps from some viewers as it circulated recently on social media. The protesters, who were HIV positive, did not conceal their faces — a rare occurrence in a country where the virus is still heavily stigmatized.
'Call the minister of health! We are dying!' the group chanted.
The protesters risked being shunned by society to warn that Haiti is running out of HIV medication just months after the administration of U.S. President Donald Trump slashed more than 90% of USAID's foreign aid contracts and $60 billion in overall aid across the globe.
At a hospital near the northern city of Cap-Haitien, Dr. Eugene Maklin said he struggles to share that reality with his more than 550 HIV patients.
'It's hard to explain to them, to tell them that they're not going to find medication,' he said. 'It's like a suicide.'
'We can't stay silent'
More than 150,000 people in Haiti have HIV or AIDS, according to official estimates, although nonprofits believe the number is much higher.
David Jeune, a 46-year-old hospital community worker, is among them. He became infected 19 years ago after having unprotected sex. 'I was scared to let people know because they would point their finger at you, saying you are infecting others with AIDS,' he said.
His fear was so great that he didn't tell anyone, not even his mother. But that fear dissipated with the support Jeune said he received from nonprofits. His confidence grew to the point where he participated in Monday's protest.
'I hope Trump will change his mind,' he said, noting that his medication will run out in November. 'Let the poor people get the medication they need.'
Patrick Jean Noël, a representative of Haiti's Federation of Associations of HIV, said that at least five clinics, including one that served 2,500 patients, were forced to close after the USAID funding cuts.
'We can't stay silent,' he said. 'More people need to come out.'
But most people with HIV in Haiti are reluctant to do so, said Dr. Sabine Lustin, executive director of the Haiti-based nonprofit Promoters of Zero AIDS Goal.
The stigma is so strong that many patients are reluctant to pick up their medication in person. Instead, it is sent via packages wrapped as gifts to not arouse suspicion, Lustin said.
Lustin's organization, which helps some 2,000 people across Haiti, receives funding from the U.S. Centers for Disease Control and Prevention. While their funding hasn't been cut, she said that shortly after Trump was sworn in, the agency banned prevention activities because they targeted a group that is not a priority. By that, Lustin said she understood they were referring to gay men.
That means the organization can no longer distribute up to 200,000 free condoms a year or educate people about the disease.
'You risk an increase in infections,' she said. 'You have a young population who is sexually active who can't receive the prevention message and don't have access to condoms.'
'We only have medication until July'
On a recent sunny morning, a chorus of voices drowned out the din of traffic in Haiti's capital, growing louder as protesters with HIV marched defiantly toward the office of Haiti's prime minister.
'We are here to tell the government that we exist, and we are people like any other person,' one woman told reporters.
Another marching alongside her said, 'Without medication, we are dying. This needs to change.'
Three days after Monday's protest, the leader of Haiti's transitional presidential council, Louis Gérald Gilles, announced that he had met with activists and would try to secure funding.
Meanwhile, nonprofit organizations across Haiti are fretting.
'I don't know what we're going to do,' said Marie Denis-Luque, founder and executive director of CHOAIDS, a nonprofit that cares for Haitian orphans with HIV/AIDS. 'We only have medication until July.'
Her voice broke as she described her frantic search for donations for the orphans, who are cared for by HIV-positive women in Cap-Haitien after gang violence forced them to leave Port-au-Prince.
Denis-Luque said she has long advocated for the orphans' visibility.
'We can't keep hiding these children. They are part of society,' she said, adding that she smiled when she saw the video of Monday's protest. 'I was like, whoa, things have changed tremendously. The stigma is real, but I think what I saw … was very encouraging to me. They can't be silenced.'
A dangerous combination
Experts say Haiti could see a rise in HIV infections because medications are dwindling at a time that gang violence and poverty are surging.
Dr. Alain Casseus, infectious disease division chief at Zamni Lasante, the largest non-governmental healthcare provider in Haiti, said they expected to see a surge in patients given the funding cuts, but that hasn't happened because traveling by land in Haiti is dangerous since violent gangs control main roads and randomly open fire on vehicles.
He warned that abruptly stopping medication is dangerous, especially because many Haitians do not have access or cannot afford nutritious food to strengthen their immune system.
'It wouldn't take long, especially given the situation in Haiti, to enter a very bad phase,' he said of HIV infections. And even if some funding becomes available, a lapse in medication could cause resistance to it, he said.
Casseus said gang violence also could accelerate the rates of infection via rapes or physical violence as medication runs out.
At the New Hope Hospital run by Maklin in Haiti's northern region, shelves are running empty. He used to receive more than $165,000 a year to help HIV/AIDS patients. But that funding has dried up.
'Those people are going to die,' he said. 'We don't know how or where we're going to get more medication.'
The medication controls the infection and allows many to have an average life expectancy. Without it, the virus attacks a person's immune system, and they develop AIDS, the late stage of an HIV infection.
Reaction is swift when Dr. Maklin tells his patients that in two months, the hospital won't have any HIV medication left.
'They say, 'No, no, no, no!'' he said. 'They want to keep living.'
___
Coto reported from San Juan, Puerto Rico.
____
Follow AP's coverage of Latin America and the Caribbean at https://apnews.com/hub/latin-america
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Autoimmune Skin Diseases Tied to Better Cancer Survival
Autoimmune Skin Diseases Tied to Better Cancer Survival

Medscape

time2 hours ago

  • Medscape

Autoimmune Skin Diseases Tied to Better Cancer Survival

TOPLINE: Patients with autoimmune skin diseases (ASDs) showed significantly lower risks for death after cancer treatment than those without ASDs, especially those with alopecia areata or Sjögren syndrome. METHODOLOGY: A population-based cohort study analyzed data from Taiwan's Nationwide Cancer Registry and National Health Insurance Database between January 2019 and June 2021. Researchers evaluated 197,895 adults, including 26,008 with ASD (mean age, 64 years; 57.6% women) and 171,887 who did not have an ASD (mean age, 62.8 years; 46.9% women), who received antineoplastic treatment, including chemotherapy, targeted therapy, or immunotherapy. Primary outcomes were all-cause mortality and cancer-specific mortality. The mean follow-up was 566.7 days. TAKEAWAY: Patients with ASDs showed a significantly lower risk for all-cause mortality (adjusted hazard ratio [aHR], 0.93; P < .001) and cancer-specific mortality (aHR, 0.93; P < .001) than those without ASDs, adjusted for factors including age, sex, and prior immunosuppressive drug use. Alopecia areata showed the strongest association with reduced all-cause mortality risk (aHR, 0.82; P < .001), followed by Sjögren syndrome (aHR, 0.87; P < .001), vitiligo (aHR, 0.89; P < .05), and lupus erythema (aHR, 0.90; P < .05). Similarly, patients with alopecia areata showed the highest inverse associations with cancer-specific mortality (aHR, 0.82; P < .001), followed by those with Sjögren syndrome (aHR, 0.88; P < .001), vitiligo (aHR, 0.88; P < .05), and lupus erythema (aHR, 0.81; P < .001). The associations remained consistent after adjusting for potential confounders and across most cancer types, stages, and treatment regimens. IN PRACTICE: 'This population-based cohort study demonstrated that patients with ASDs, particularly alopecia areata and Sjögren syndrome, experienced better survival outcomes, indicating that ASDs play an important role in cancer prognosis,' the study authors wrote. 'Future studies are necessary to better understand the underlying immune mechanisms and explore how this knowledge can be applied to enhance patient care,' they added. SOURCE: The study was led by Li-Ting Kao, PhD, School of Pharmacy, National Defense Medical Center in Taipei, Taiwan, and was published online on July 2 in JAMA Dermatology. LIMITATIONS: The study did not account for potential confounding factors such as lifestyle factors, genetic predisposition, and environmental exposures. Additionally, clinical data on ASD severity, such as the extent of skin lesions, were unavailable. DISCLOSURES: The study received support through grants from the Ministry of Science and Technology, Taiwan. Kao disclosed receiving grants from IQVIA outside the submitted work. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

How A.I. Made Me More Human, Not Less
How A.I. Made Me More Human, Not Less

New York Times

time2 hours ago

  • New York Times

How A.I. Made Me More Human, Not Less

Most nights, after my husband and children had gone to bed, I would curl into the corner of our old sectional — the cream-colored one with years of baby stains baked into the cushions, too loved to replace. I always took the same spot, next to the right armrest. But one night, when I opened my laptop, my hands trembled. Everything around me looked ordinary. My chest hummed with nervous energy, as if I was about to confess something I hadn't fully admitted to myself. I didn't know what I wanted to say or what kind of response I was hoping for. And underneath it all, a flicker of shame: What kind of person pours their heart out to an A.I.-bot? I placed my fingers on the keyboard and typed, 'I'm scared I'm disappearing.' At 39, I had been diagnosed with epilepsy after a long stretch of unexplained symptoms and terrifying neurological episodes. It began with a wave of déjà vu so intense that it stole my breath, followed by dread, confusion and the eerie sense that I was both inside my body and nowhere at all. For years, these moments had gone ignored or been misread. Then one afternoon, as I stood in my kitchen with the phone to my ear, I heard the words from the neurologist that would change my life forever: 'Your EEG showed abnormal activity. It's consistent with epilepsy.' Outside, the air was crisp, the sky cloudless, but within me a storm was brewing. The relief of having a diagnosis gave way to something heavier. Fog. Exhaustion. I wasn't dying. But I didn't feel alive either. Want all of The Times? Subscribe.

What Are the Stages of Eczema?
What Are the Stages of Eczema?

Health Line

time3 hours ago

  • Health Line

What Are the Stages of Eczema?

Key takeaways Eczema is divided into acute, subacute, and chronic stages, each with unique symptoms and durations. Eczema may be lifelong, but severity varies, and remission periods are possible. Treatments for eczema, which include moisturizers and trigger avoidance, focus on supporting the skin's barrier to prevent irritants from causing flares. Severe cases may need medical treatments like corticosteroids, calcineurin inhibitors, or biologics. A doctor may diagnose eczema and its stages through medical history and symptom evaluation. They may recommend tests to rule out other conditions. Talk with a doctor if symptoms worsen, don't improve with home treatments, or show signs of infection. Eczema can be a lifelong condition. However, you may experience periods of remission, where there are no symptoms, and flares, where symptoms come back. The severity of flares can differ. Learn more about the three stages of eczema, including their similarities and differences from a symptom and treatment standpoint. Stages of eczema and their symptoms There are three main stages of eczema. It's possible to identify each stage of eczema by molecular changes in skin lesions and onset, according to 2020 research. You can also have more than one type of eczema at the same time. Here's how each stage of eczema is classified and what the common symptoms look and feel like. Acute eczema Acute eczema consists of more severe symptoms, including rashes that: may be filled with fluids are leaking fluids (a process called weeping) have crusted These symptoms are in addition to the swelling, skin discoloration, and itchiness you may experience during any stage of eczema. The word 'acute' generally means severe and short lasting. As its name suggests, acute eczema refers to sudden flare-ups that may be more severe but will go away with focused treatment. Subacute eczema Subacute eczema is marked by mild to moderate inflammation that may come and go throughout your lifetime. In addition to some of the more common symptoms of eczema, such as itchiness and discolored skin, you may also notice raised bumps (papules) and swollen lesions. Chronic eczema Atopic dermatitis is a common chronic type of eczema. Chronic eczema consists of lesions and papules that may be enlarged and thickened. If eczema is chronic, you may notice leathery or thickened areas of skin from previous rashes. Unlike acute eczema, chronic eczema flares tend to be more persistent. Also, unlike acute or subacute eczema, the chronic stage does not cause significant swelling. Pictures of eczema stages Does eczema get better? Depending on the underlying causes of eczema, including genetic and environmental factors, symptoms can come and go throughout your lifetime. For example, a type of eczema called contact dermatitis will usually improve once you remove the irritant or allergen that has triggered your symptoms. Avoiding the trigger can help prevent further cases of contact dermatitis. Some types, such as atopic dermatitis, are not completely curable. However, treatments can help improve your symptoms and prevent underlying inflammation that contributes to flares. Some children may even experience improvement in their eczema after they reach adulthood. Treating eczema at its three stages Treatment for eczema primarily consists of strategies to support a leaky skin barrier to prevent irritants from causing flares. Common treatments include using moisturizers or emollients for dry skin and avoiding possible triggers, such as allergens. These strategies may help treat eczema at any of its three stages, but you may need additional treatments in the case of severe eczema. Possible medical treatments include: topical or oral corticosteroids to control inflammation topical calcineurin inhibitors to reduce inflammation when other creams don't work Janus kinase (JAK) inhibitors to help stop inflammation in severe cases injectable biologics You can work with your doctor to create a suitable treatment plan for eczema. You may require different treatments if your symptoms change or worsen. Learn about natural remedies for eczema. How do doctors diagnose the three stages of eczema? A doctor may be able to diagnose eczema based on your medical history and the symptoms you experience. A doctor can also identify eczema stages based on additional symptoms. For example, weeping lesions may indicate acute eczema. Swollen, raised plaques and bumps could be signs of the subacute stage. In some cases, a doctor may recommend tests, such as: a skin biopsy allergy tests blood tests These tests can help rule out other causes of your skin rashes, such as contact dermatitis or psoriasis, and help them make a more definitive diagnosis. When to contact a doctor No matter what stage of eczema you may have, this skin condition may potentially lead to issues that affect your health and quality of life. Consider seeing a doctor if you: notice your symptoms are worsening despite treatment have tried home treatments, such as moisturizers and over-the-counter ointments, and your condition is not improving have itchiness, pain, and other symptoms that are disrupting your sleep are experiencing rashes with fluid-filled lesions or any oozing have signs of infection in eczema rashes, such as thick-colored fluids, swelling, or pain Learn about infected eczema. The bottom line A doctor may classify eczema into three stages: acute, subacute, or chronic. Each stage carries slight variations in symptoms and outlook. As a common skin condition, eczema may come in various forms. Its triggers are also highly individual. You can work with your doctor to identify the stage of eczema and any triggers that may be causing or worsening symptoms.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store